Senti Biosciences Holdings, Inc. (SNTI) stock
SNTINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.10−0.04 (-28.68%)
Close on Nov 17, 2026Market cap $3.02MP/E –Yield –
Senti Biosciences price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Senti Biosciences's price to book ratio was 4.1× on Jul 31, 2026, against 1.2× a year earlier. Over the last 4 years it ranged from 0.1× to 13.4×, with a median of 0.6×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 4.1× | +0.8 |
| 2025 | Dec 31, 2025 | 3.4× | +2.4 |
| 2024 | Dec 31, 2024 | 1.0× | +0.7 |
| 2023 | Dec 29, 2023 | 0.4× | −0.1 |
| 2022 | Dec 30, 2022 | 0.4× | – |
See a number that looks wrong?